Definition: An oral epidermal-growth-factor (EGFR) inhibitor used in malignancies with either mutated or overactive EGFR; most commonly used in the treatment of lung cancers.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.